BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Cognoptix 

20 Main Street

Acton   Massachusetts  01720  U.S.A.
Phone: 978-263-0005 Fax: 978-263-0015


SEARCH JOBS


Industry
Diagnostics






 Company News
Cognoptix President And CEO Paul Hartung Tells Analysts: “Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care.” 4/2/2014 7:42:27 AM    More...
Cognoptix Eye Test Generates Robust Results in Clinical Study to Identify Alzheimer’s Disease 2/14/2014 9:51:08 AM    More...
Cognoptix President And CEO Paul Hartung Named "Emerging Medical Technologies Innovator Of The Month" By Life Science Intelligence® 12/5/2013 8:03:53 AM    More...
Cognoptix Eye Test Shows Impressive Results In Clinical Study To Identify Alzheimer’s Disease: 85% Sensitivity And 95% Specificity 11/15/2013 9:26:47 AM    More...
Inventages Portfolio Company, Cognoptix, Demonstrates the Ability to Accurately Identify Alzheimer's Disease 10/4/2013 9:00:27 AM    More...
Clinical Investigators Comment on Their Study of Cognoptix Eye Test Designed to Identify Alzheimer's Disease That Showed Strong Results: 85% Sensitivity and 95% Specificity 9/30/2013 11:20:01 AM    More...
Company Profile for Cognoptix 9/27/2013 9:28:53 AM    More...
Cognoptix Eye Test Designed to Identify Alzheimer’s Disease Shows Strong Results: 85% Sensitivity and 95% Specificity 9/23/2013 12:45:00 PM    More...
Cognoptix Advisory: Can Alzheimer's Be Detected a Decade Earlier? 8/19/2013 9:55:38 AM    More...

//-->